StonvexLoading…
StonvexStonvexStonvexCore line items from ZG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.58B | $2.24B | $1.95B | $1.96B |
Operating Income | $-34.00M | $-197.00M | $-270.00M | $-93.00M |
Net Income | $23.00M | $-112.00M | $-158.00M | $-101.00M |
EPS (Diluted) | $0.09 | $-0.48 | $-0.68 | $-0.42 |
Total Assets | $5.68B | $5.83B | $6.65B | $6.56B |
Total Liabilities | $801.00M | $981.00M | $2.13B | $2.08B |
Cash & Equivalents | $768.00M | $1.08B | $1.49B | $1.47B |
Free Cash Flow OCF − CapEx | $235.00M | $285.00M | $219.00M | $4.39B |
Shares Outstanding | 254.12M | 234.08M | 233.57M | 242.16M |